- Projects & figures
- News & Events
- Managing your project
- About ERC
Sino alla metà del XV secolo, i libri venivano scritti a mano. Nel 1455 venne stampata la Bibbia di Gutenberg, cambiando per sempre la società. Negli anni successivi milioni di libri furono stampati in tutta Europa. Cosa si sa oggi di questi libri? Chi li leggeva? Chi li acquistava? Chi li annotava? Cristina Dondi è una ricercatrice dell'Università di Oxford e curatrice della mostra "Printing Revolution 1450-1500. I 50 anni che hanno cambiato l'Europa" aperta al Museo Correr di Venezia lo scorso settembre. Forte del successo ottenuto, con oltre 90 000 visitatori a dicembre 2018, la mostra è stata prolungata sino al 30 aprile 2019. Un percorso di scoperta attraverso libri antichi e moderni strumenti digitali, frutto di anni di rigorose ricerche finanziate dall'ERC, il Consiglio europeo delle Ricerche. Sentiamo in questa intervista come nasce la passione di Cristina Dondi per i primi libri a stampa e cosa ha scoperto con le sue ultime ricerche che l'hanno portata a collaborare con biblioteche di tutto il mondo.
Until the middle of the 15th century, books were copied by hand. After the printing of the Gutenberg Bible, in Mainz, printed books started to circulate in Europe marking the start of a new era. But what do we know about the first modern books? What were they about? Who wrote them, bought them, read them? Prof. Cristina Dondi is chasing these answers, following the breadcrumbs left by these incredible volumes.
Water is a peculiar liquid. In fact, it's thanks to some of its peculiarities that our "blue" planet looks the way it does, and that life has evolved most of the characteristics we recognise today. ERC grantee Prof. Anders Nilsson has made his career out of studying water, in particular trying to understand the secret double life water leads at extremely cold temperatures.
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex vivo three-dimensional organoid cultures that replicate genetic events in CRC, as tools to test novel therapeutics.
Dr Joaquim Alves Gaspar is a man of the sea. After many years in the Portuguese Navy, he gave up plans to become an admiral in favour of pursuing a PhD in the History of Cartography. This second career led him to receive an ERC Starting Grant, the first awarded in this budding discipline. With his highly multidisciplinary team (he likes to say that, to work with him, one must be a mathematician fluent in Latin), and the experience obtained as a navigator and navigational instructor, Dr Gaspar hopes to understand how and when the first nautical charts were created. The MEDEA-CHART team is the best place in Portugal, and probably in the world, to study the history of nautical cartography, hoping that this work will provide the domain with its rightful recognition within world history.
After the birth of quantum mechanics in the early 20th century, this branch of physics evolved from being primarily the conceptual framework for the description of subatomic particle phenomena to providing inspiration for new technological applications. New hybrid architecture of quantum systems is now being developed in order to foster the implementation of cutting-edge quantum technologies.
Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira, founded StemCell2MAX in 2015. The company is a biotechnology start-up, specialised in cell based therapies, including novel solutions to multiply the scarcely available blood stem cells, addressing an enormous demand for research and cancer treatment. StemCell2MAX technology is based on Prof. Veiga-Fernandes's ground-breaking discoveries in hematopoietic stem cell biology.
Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."
An ERC-funded project has significantly increased understanding of the crucial role that microorganisms in the gut play in maintaining health. The findings have since led to a patent, as well as a follow-on project that could one day steer the way to new targeted treatments for diseases, including cancer.
Through her work with the fruit fly Drosophila santomea, Dr Virginie Orgogozo aims to answer one of the most challenging questions of modern evolutionary biology: how do observable characteristics change between species and yet remain stable in a given species?
Haematopoietic Stem Cells (HSCs) are blood cells located in the bone marrow. These cells are extensively used in research to develop treatments for many severe diseases, including HIV and multiple sclerosis, and their transplant is a key therapy for certain types of cancer like leukemia and multiple myeloma. However, the use of HSCs is seriously constrained by their limited availability since growing them in the lab does not produce very large quantities. There is therefore an urgent need for methods allowing scientists to multiply HSCs, without losing any of their properties.